Caglar Esber, Cildir Sule Kavaloglu, Ergeneli Semra, Sandalli Nuket, Twetman Svante
Department of Paediatric Dentistry, Dental School, Yeditepe University, Istanbul, Turkey.
Acta Odontol Scand. 2006 Oct;64(5):314-8. doi: 10.1080/00016350600801709.
Previous studies have suggested that lactobacilli-derived probiotics in dairy products may affect oral ecology, but the impact of different vehicles of ingestion has received little attention. The aim of the present study was to investigate the effect of the probiotic bacterium Lactobacillus reuteri ATCC 55730 on the levels of salivary mutans streptococci and lactobacilli in young adults when ingested by two different delivery systems.
The material comprised 120 healthy young adults (21-24 years) and a placebo-controlled study design with parallel arms was utilized. The subjects were randomly assigned to four equally sized groups: group A drank 200 ml of water through a prepared straw containing L. reuteri ATCC 55730 once daily for 3 weeks, while group B took 200 ml water through a placebo straw during the same period. Group C was given one tablet containing L. reuteri ATCC 55730 once daily for 3 weeks, while group D received placebo tablets without bacteria. Salivary mutans streptococci and lactobacilli were enumerated with chair-side kits at baseline and 1 day after the final ingestion.
A statistically significant reduction of the mutans streptococci levels was recorded after ingestion of the probiotic bacteria via the straw (p<0.05) and the tablets (p<0.01), which was in contrast to the placebo controls. A similar but non-significant trend was seen for lactobacilli.
A short-term daily ingestion of lactobacilli-derived probiotics delivered by prepared straws or lozenges reduced the levels of salivary mutans streptococci in young adults.
以往研究表明,乳制品中源自乳酸杆菌的益生菌可能会影响口腔生态,但不同摄入载体的影响鲜受关注。本研究旨在调查益生菌罗伊氏乳杆菌ATCC 55730通过两种不同递送系统摄入时,对年轻成年人唾液变形链球菌和乳酸杆菌水平的影响。
材料包括120名健康年轻成年人(21 - 24岁),采用平行组的安慰剂对照研究设计。受试者被随机分为四个等规模组:A组每天通过装有罗伊氏乳杆菌ATCC 55730的特制吸管饮用200毫升水,持续3周,而B组在同一时期通过安慰剂吸管饮用200毫升水。C组每天服用一片含有罗伊氏乳杆菌ATCC 55730的片剂,持续3周,而D组接受不含细菌的安慰剂片剂。在基线和最后一次摄入后1天,使用椅旁试剂盒对唾液变形链球菌和乳酸杆菌进行计数。
通过吸管(p<0.05)和片剂(p<0.01)摄入益生菌后,变形链球菌水平出现统计学显著降低,这与安慰剂对照组形成对比。乳酸杆菌呈现类似但不显著的趋势。
年轻成年人每日短期摄入通过特制吸管或含片递送的源自乳酸杆菌的益生菌,可降低唾液变形链球菌水平。